Myeloma Multiple Clinical Trials
3 recruiting trials for Myeloma Multiple. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGPhase 2NCT05091372
Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autologous...
To increase the conversion rate from MRD-positive to MRD-negative CR in patients with newly diagnosed multiple myeloma (NDMM) receiving post-transplant maintenance therapy with...
Sponsor: M.D. Anderson Cancer CenterEnrolling: 941 location
RECRUITINGPhase 2NCT05932680
Limited-duration Teclistamab
This is a single-arm, non-inferiority study in which patients who have achieved a very good partial response (VGPR) or better, according to International Myeloma Working Group...
Sponsor: Abramson Cancer Center at Penn MedicineEnrolling: 755 locations
RECRUITINGNCT07205523
High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
The High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT) study is the first prospective real-world cohort of hematologic diseases and transplantation in the...
Sponsor: Yigeng Cao,MD,PhDEnrolling: 10001 location